// App-Quantinova.ai

BSH2020‐EP‐025 : A little learning is a dangerous thing – how little do we know about when to treat pulmonary embolism?

Researchers

Presenter

  • M. Maybury

Principal Investigators

  • B. Maybury

Medical Centers

  • School of Medicine, University of St Andrews, St Andrews, UNITED KINGDOM

  • The Francis Crick Institute, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Ophthalmology (OP)

  • Pulmonary/Respiratory Diseases

  • Gastroenterology (GU)

  • Genetic Disorder

Disease

  • Venous thrombosis

  • Deep vein thrombosis

  • Pulmonary embolism

  • Peptic ulcer

  • Cataract 6, multiple types

Biomarkers

  • EPH Receptor A2

Drug/Treatment

  • Fondaparinux sodium

  • Heparin

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved